The company will acquire a majority interest in TriMed and enter a strategic relationship with Extremity Medical.

The transaction will allow ZimVie to streamline operations and sharpen its focus as a well-positioned, pure-play dental company in higher-growth end markets.

SERF is recognized worldwide for its innovations in hip implants, including the invention of the original Dual Mobility Cup.

Orthopedic M&A is more active and has higher multiples than general medtech, but economic conditions will limit growth for now.

Vyrsa manufactures and supports a complete portfolio of FDA-cleared sacroiliac joint fusion devices.

TeDan produces surgical access systems with a specialty focus in spine, neuro, orthopedic and cardiothoracic surgery.

Agili-C is a novel sports medicine technology developed to treat cartilage regeneration in the knee.

Xtant acquired certain assets, including equipment and inventory, used in RTI’s synthetic bone graft business and assumed the lease for the nanOss production facility.

The merger will integrate Advanced Biologics’ proprietary products into Isto’s growing portfolio of allografts in their Influx line.

Lima’s solutions include digital innovation and patient-tailored hardware, developed to improve patient outcomes following joint replacement surgery.